Bio-Techne (BSP:T1CH34) Other Long Term Assets : R$120 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Other Long Term Assets?

Bio-Techne's other long-term assets for the quarter that ended in Mar. 2024 was R$120 Mil.

Bio-Techne's quarterly other long-term assets declined from Sep. 2023 (R$148 Mil) to Dec. 2023 (R$121 Mil) but then stayed the same from Dec. 2023 (R$121 Mil) to Mar. 2024 (R$120 Mil).

Bio-Techne's annual other long-term assets increased from Jun. 2021 (R$58 Mil) to Jun. 2022 (R$236 Mil) and increased from Jun. 2022 (R$236 Mil) to Jun. 2023 (R$1,385 Mil).

Bio-Techne Other Long Term Assets Historical Data

The historical data trend for Bio-Techne's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Other Long Term Assets Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long Term Assets

Get a 7-Day Free Trial

21.85

70.16

58.21

236.37

1,384.77

Bio-Techne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															1,475.88	1,384.77	147.83	120.68	120.29

Bio-Techne Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Bio-Techne (BSP:T1CH34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines